Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 78

1.

[Therapy of dementia with antipsychotics and antidepressives].

Frölich L, Hausner L.

Nervenarzt. 2015 Apr;86(4):461-7. doi: 10.1007/s00115-014-4178-4. Review. German.

PMID:
25787724
2.

Trends in use of psychotropic medications among patients treated with cholinesterase inhibitors in Japan from 2002 to 2010.

Okumura Y, Togo T, Fujita J.

Int Psychogeriatr. 2015 Mar;27(3):407-15. doi: 10.1017/S1041610214001975. Epub 2014 Sep 12. Erratum in: Int Psychogeriatr. 2015 Mar;27(3):417-8.

PMID:
25213318
3.

Incidence of tardive dyskinesia in older adult patients treated with olanzapine or conventional antipsychotics.

Kinon BJ, Kollack-Walker S, Jeste D, Gupta S, Chen L, Case M, Chen J, Stauffer V.

J Geriatr Psychiatry Neurol. 2015 Mar;28(1):67-79. doi: 10.1177/0891988714541867. Epub 2014 Jul 9.

PMID:
25009161
4.

Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.

Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, Christiaens T.

Cochrane Database Syst Rev. 2013 Mar 28;3:CD007726. doi: 10.1002/14651858.CD007726.pub2. Review.

PMID:
23543555
5.

Physicians' practice and familiarity with treatment for agitation associated with dementia in Israeli nursing homes.

Cohen-Mansfield J, Juravel-Jaffe A, Cohen A, Rasooly I, Golander H.

Int Psychogeriatr. 2013 Feb;25(2):236-44. doi: 10.1017/S104161021200172X. Epub 2012 Oct 30.

PMID:
23174135
6.

Management of acute agitation in the emergency department.

Baker SN.

Adv Emerg Nurs J. 2012 Oct-Dec;34(4):306-18; quiz 319-20. doi: 10.1097/TME.0b013e31826f12d6.

PMID:
23111305
7.

How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia.

Galeotti F, Vanacore N, Gainotti S, Izzicupo F, Menniti-Ippolito F, Petrini C, Chiarotti F, Chattat R, Raschetti R; AdCare Study Group.

Drugs Aging. 2012 Aug 1;29(8):607-14. doi: 10.2165/11630810-000000000-00000.

PMID:
22574633
8.

A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease.

Devanand DP, Pelton GH, Cunqueiro K, Sackeim HA, Marder K.

Int J Geriatr Psychiatry. 2011 Sep;26(9):937-43. doi: 10.1002/gps.2630. Epub 2010 Dec 28.

9.

Antidepressants for agitation and psychosis in dementia.

Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD008191. doi: 10.1002/14651858.CD008191.pub2. Review.

PMID:
21328305
10.

Cyproterone to treat aggressivity in dementia: a clinical case and systematic review.

Bolea-Alamanac BM, Davies SJ, Christmas DM, Baxter H, Cullum S, Nutt DJ.

J Psychopharmacol. 2011 Jan;25(1):141-5. doi: 10.1177/0269881109353460. Epub 2009 Nov 26. Review.

PMID:
19942637
11.

Valproate-induced delirium in a demented patient.

Gareri P, Lacava R, Cotroneo A, Bambara V, Marigliano N, Castagna A, Costantino DS, Ruotolo G, de Sarro G.

Arch Gerontol Geriatr. 2009;49 Suppl 1:113-8. doi: 10.1016/j.archger.2009.09.019.

PMID:
19836623
12.

Benzodiazepines for delirium.

Lonergan E, Luxenberg J, Areosa Sastre A.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006379. doi: 10.1002/14651858.CD006379.pub3. Review.

PMID:
19821364
13.

Multifocal myoclonus induced by haloperidol.

Domínguez C, Benito-León J, Bermejo-Pareja F.

Neurol Sci. 2009 Oct;30(5):385-6. doi: 10.1007/s10072-009-0104-0. Epub 2009 Jun 13.

PMID:
19526195
14.

Benzodiazepines for delirium.

Lonergan E, Luxenberg J, Areosa Sastre A, Wyller TB.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006379. doi: 10.1002/14651858.CD006379.pub2. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD006379.

PMID:
19160280
15.

Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy.

Salzman C, Jeste DV, Meyer RE, Cohen-Mansfield J, Cummings J, Grossberg GT, Jarvik L, Kraemer HC, Lebowitz BD, Maslow K, Pollock BG, Raskind M, Schultz SK, Wang P, Zito JM, Zubenko GS.

J Clin Psychiatry. 2008 Jun;69(6):889-98. Review.

16.

Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic.

Preskorn SH.

J Psychiatr Pract. 2008 Jan;14(1):45-54. doi: 10.1097/01.pra.0000308494.00628.0a. No abstract available.

PMID:
18212602
17.

Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient.

Gareri P, De Fazio P, Cotroneo A, Lacava R, Gallelli L, De Fazio S, De Sarro G.

Arch Gerontol Geriatr. 2007;44 Suppl 1:199-206.

PMID:
17317453
18.

[New formulations of olanzapine in the treatment of acute agitation].

Bartkó G.

Neuropsychopharmacol Hung. 2006 Dec;8(4):171-8. Review. Hungarian.

PMID:
17211052
19.

The evaluation and management of the acutely agitated elderly patient.

Nassisi D, Korc B, Hahn S, Bruns J Jr, Jagoda A.

Mt Sinai J Med. 2006 Nov;73(7):976-84. Review.

PMID:
17195883
20.

Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients.

Lacasse H, Perreault MM, Williamson DR.

Ann Pharmacother. 2006 Nov;40(11):1966-73. Epub 2006 Oct 17. Review.

PMID:
17047137
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk